Long-Sen Chang Selected Research

notexin

12/2014	Modulated mechanism of phosphatidylserine on the catalytic activity of Naja naja atra phospholipase A2 and Notechis scutatus scutatus notexin.
4/2010	Notexin upregulates Fas and FasL protein expression of human neuroblastoma SK-N-SH cells through p38 MAPK/ATF-2 and JNK/c-Jun pathways.
1/2010	Calcium-stimulated mitogen-activated protein kinase activation elicits Bcl-xL downregulation and Bak upregulation in notexin-treated human neuroblastoma SK-N-SH cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Long-Sen Chang Research Topics

Disease

45	Leukemia 07/2022 - 06/2007
30	Neoplasms (Cancer) 01/2022 - 06/2007
15	Breast Neoplasms (Breast Cancer) 09/2021 - 02/2010
10	Neuroblastoma 09/2010 - 02/2008
9	Neoplasm Metastasis (Metastasis) 11/2016 - 02/2010
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2022 - 01/2020
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 10/2009
5	Melanoma (Melanoma, Malignant) 10/2017 - 06/2007
3	Squamous Cell Carcinoma of Head and Neck 09/2010 - 10/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2014 - 10/2009
2	Adenocarcinoma of Lung 01/2010 - 09/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2009 - 06/2007
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021
1	autosomal dominant familial Periodic fever 01/2021
1	Inflammation (Inflammations) 01/2021
1	Cryopyrin-Associated Periodic Syndromes 01/2021
1	Carcinogenesis 01/2015

Drug/Important Bio-Agent (IBA)

19	p38 Mitogen-Activated Protein KinasesIBA 03/2022 - 07/2008
9	CardiotoxinsIBA 12/2021 - 06/2007
8	Phospholipases (Phospholipase)IBA 11/2011 - 01/2009
7	hydroquinone (Esoterica)FDA Link 07/2022 - 04/2013
6	VenomsIBA 03/2016 - 06/2007
6	Caspase 8 (Caspase-8)IBA 01/2016 - 12/2009
6	N-formyl-13-dihydrocarminomycin (NFD)IBA 09/2014 - 01/2010
5	Cobra Cardiotoxin ProteinsIBA 12/2021 - 08/2008
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2010
5	Epidermal Growth Factor (EGF)IBA 11/2016 - 06/2010
5	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2014 - 09/2010
5	Phospholipases A2 (Phospholipase A2)IBA 12/2014 - 07/2008
5	furanIBA 02/2014 - 01/2010
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2010
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2016 - 12/2014
4	Matrix Metalloproteinases (MMPs)IBA 12/2014 - 09/2012
4	CaspasesIBA 09/2011 - 06/2007
3	Sirtuin 3IBA 03/2022 - 01/2019
3	Benzene (Benzole)IBA 03/2022 - 01/2020
3	Amsacrine (AMSA)IBA 01/2018 - 05/2014
3	Gallic AcidIBA 11/2016 - 09/2012
3	Peptides (Polypeptides)IBA 03/2016 - 06/2007
3	notexinIBA 12/2014 - 01/2010
3	ErbB Receptors (EGF Receptor)IBA 02/2013 - 10/2009
3	IN6CPBDIBA 09/2011 - 06/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2010 - 03/2008
3	Arachidonic Acid (Vitamin F)IBA 03/2010 - 08/2009
3	DiaminesIBA 09/2009 - 10/2007
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 03/2022 - 09/2013
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2022 - 11/2021
2	SurvivinIBA 01/2021 - 01/2020
2	sepantroniumIBA 01/2021 - 01/2020
2	AnthelminticsIBA 05/2020 - 01/2019
2	Albendazole (Albenza)FDA Link 05/2020 - 01/2019
2	Arsenic Trioxide (Trisenox)FDA Link 04/2020 - 11/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 06/2007
2	navitoclaxIBA 01/2020 - 01/2018
2	Quinacrine (Mepacrine)IBA 11/2017 - 04/2015
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2016 - 05/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 09/2011
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2014 - 08/2014
2	Caffeine (No Doz)FDA LinkGeneric 09/2013 - 09/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013 - 05/2012
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2013 - 07/2008
2	3,3',4,5'-tetrahydroxystilbeneIBA 09/2012 - 09/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 11/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2010 - 02/2010
2	Mitogen-Activated Protein KinasesIBA 01/2010 - 09/2009
2	Amino Acids FDA Link 10/2009 - 06/2007
2	NF-kappa B (NF-kB)IBA 01/2009 - 07/2008
2	Antineoplastic Agents (Antineoplastics)IBA 11/2008 - 08/2008
1	WEHI-539IBA 07/2022
1	venetoclaxIBA 07/2022
1	TristetraprolinIBA 03/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	carbamylhydrazine (semicarbazide)IBA 09/2021
1	Lactalbumin (alpha-Lactalbumin)IBA 09/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Glycogen Synthase KinasesIBA 01/2021
1	canakinumab FDA Link 01/2021
1	InterleukinsIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	benzimidazoleIBA 05/2020
1	Pemetrexed (MTA)FDA Link 05/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Protein Kinases (Protein Kinase)IBA 12/2019
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 11/2017
1	TriazolesIBA 10/2017
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 03/2017
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2017
1	Aminacrine (Aminoacridine)IBA 03/2017
1	PhytochemicalsIBA 11/2016
1	GoldIBA 11/2016
1	2-(4-aminophenyl)-7-methoxybenzothiazoleIBA 01/2016
1	GlucuronidesIBA 01/2015
1	CarcinogensIBA 01/2015
1	GlucuronidaseIBA 01/2015
1	Simvastatin (Zocor)FDA LinkGeneric 12/2014
1	LuciferasesIBA 05/2014

Therapy/Procedure

4	Therapeutics 01/2021 - 10/2010
2	Photochemotherapy (Photodynamic Therapy) 10/2017 - 08/2010